Clinical trial
Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients…
NCT00002554 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002554 |
|---|---|
| Title | Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse |
| Official title | RADIOLABELED BC8 (ANTI-CD45) ANTIBODY COMBINED WITH BUSULFAN AND CYCLOPHOSPHAMIDE AS TREATMENT FOR ACUTE MYELOGENOUS LEUKEMIA IN FIRST OR SECOND REMISSION OR UNTREATED FIRST RELAPSE FOLLOWED BY HLA-IDENTICAL RELATED MARROW TRANSPLANTATION |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | busulfan, cyclophosphamide, methotrexate, allogeneic bone marrow transplantation, radioimmunotherapy |
| Enrollment | 30 |
| Start date | Nov 1, 1993 |
| Primary completion | Dec 1, 1999 |
| Completion | Dec 1, 1999 |
| First posted | Aug 31, 2004 |
| Last update posted | Mar 30, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: